Published in Best Pract Res Clin Gastroenterol on October 01, 2005
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (2010) 3.00
Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review. World J Gastrointest Oncol (2014) 1.27
Gastrin - active participant or bystander in gastric carcinogenesis? Nat Rev Cancer (2006) 1.05
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin. Eur J Nucl Med Mol Imaging (2007) 1.01
Surgical treatment of gastrointestinal neuroendocrine tumors. Langenbecks Arch Surg (2011) 0.93
Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor. Am J Physiol Gastrointest Liver Physiol (2008) 0.90
Gastric carcinoids: between underestimation and overtreatment. World J Gastroenterol (2009) 0.83
The efficacy of endoscopic submucosal dissection of type I gastric carcinoid tumors compared with conventional endoscopic mucosal resection. Gastroenterol Res Pract (2014) 0.76
Mechanism of acid hypersecretion post curative gastrinoma resection. Dig Dis Sci (2010) 0.76
Solitary Gastric Carcinoid Tumor Associated with Long-Term Use of Omeprazole: A Case Report and Review of the Literature. Dig Dis Sci (2015) 0.76
Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol (2009) 2.94
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer (2005) 2.24
Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence. Eur J Nucl Med Mol Imaging (2013) 2.06
Acute fulminant hepatitis E virus genotype 3e infection: description of the first case in Europe. Scand J Infect Dis (2014) 2.03
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod Pathol (2010) 2.00
Effect of chronic hypergastrinemia on human enterochromaffin-like cells: insights from patients with sporadic gastrinomas. Gastroenterology (2002) 1.62
Proteomic analysis of chronic pancreatitis and pancreatic adenocarcinoma. Gastroenterology (2005) 1.61
Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol (2011) 1.42
Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol (2007) 1.38
Celiac disease and CFTR mutations in patients with chronic asymptomatic pancreatic hyperenzymemia. Am J Gastroenterol (2013) 1.13
Consensus guidelines on severe acute pancreatitis. Dig Liver Dis (2015) 1.12
Lansoprazole-induced microscopic colitis: an increasing problem? Results of a prospecive case-series and systematic review of the literature. Dig Liver Dis (2010) 1.10
Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate. Neuroendocrinology (2011) 1.08
Can patient characteristics predict the outcome of endoscopic evaluation of iron deficiency anemia: a multiple logistic regression analysis. Gastrointest Endosc (2004) 1.08
Ki-67 grading of nonfunctioning pancreatic neuroendocrine tumors on histologic samples obtained by EUS-guided fine-needle tissue acquisition: a prospective study. Gastrointest Endosc (2012) 1.05
Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells. Endocr Relat Cancer (2007) 1.03
Italian consensus guidelines for chronic pancreatitis. Dig Liver Dis (2010) 1.02
Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections. Eur J Cancer (2011) 1.02
Mammalian target of rapamycin expression in poorly differentiated endocrine carcinoma: clinical and therapeutic future challenges. Target Oncol (2011) 0.97
Risk factors for disease progression in advanced jejunoileal neuroendocrine tumors. Neuroendocrinology (2011) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Serous psammocarcinoma of the ovary: a case report and review of literature. Gynecol Oncol (2005) 0.95
Expression of the proto-oncogene c-KIT in normal and tumor tissues from colorectal carcinoma patients. Int J Colorectal Dis (2004) 0.94
Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms? Tumori (2011) 0.91
Genetic alterations in poorly differentiated endocrine carcinomas of the gastrointestinal tract. Cancer (2003) 0.91
Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Neuroendocrinology (2008) 0.89
Molecular pathology and genetics of pancreatic endocrine tumours. J Mol Endocrinol (2012) 0.89
Gastric neuroendocrine tumors. Neuroendocrinology (2004) 0.89
Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One (2013) 0.88
Simultaneous intraductal papillary neoplasms of the bile duct and pancreas treated with chemoradiotherapy. World J Gastrointest Oncol (2012) 0.88
Familial pancreatic cancer in Italy. Risk assessment, screening programs and clinical approach: a position paper from the Italian Registry. Dig Liver Dis (2010) 0.88
ACTH-secreting pancreatic neoplasms associated with Cushing syndrome: clinicopathologic study of 11 cases and review of the literature. Am J Surg Pathol (2015) 0.88
Repeated transabdominal ultrasonography is a simple and accurate strategy to diagnose a biliary etiology of acute pancreatitis. Pancreas (2014) 0.87
Risk factors for sporadic pancreatic endocrine tumors: a case-control study of prospectively evaluated patients. Am J Gastroenterol (2009) 0.87
ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep (2013) 0.86
Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis. Neuroendocrinology (2015) 0.86
Peanut-like 1 (septin 5) gene expression in normal and neoplastic human endocrine pancreas. Neuroendocrinology (2005) 0.85
Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome. Pancreas (2014) 0.85
Imaging of leiomyosarcoma of the inferior vena cava: comparison of 2 cases and review of the literature. Cancer Imaging (2010) 0.85
Src kinase activity coordinates cell adhesion and spreading with activation of mammalian target of rapamycin in pancreatic endocrine tumour cells. Endocr Relat Cancer (2011) 0.85
Intragastric ascorbic but not uric acid is depleted in relation with the increased pH in patients with atrophic body gastritis and H. pylori gastritis. Helicobacter (2003) 0.83
Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives. Crit Rev Oncol Hematol (2009) 0.83
Microscopic esophagitis and Barrett's esophagus: the histology report. Dig Liver Dis (2011) 0.83
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Nasogastric or nasointestinal feeding in severe acute pancreatitis. World J Gastroenterol (2010) 0.81
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases. Med Oncol (2015) 0.81
Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problems. Int J Mol Sci (2012) 0.81
The role of combined Ga-DOTANOC and (18)FDG PET/CT in the management of patients with pancreatic neuroendocrine tumors. Neuroendocrinology (2014) 0.80
Oesophageal GIST: MDCT findings of two cases and review of the literature. J Gastrointest Cancer (2012) 0.80
Outcomes of intraductal papillary mucinous neoplasm with "Sendai-positive" criteria for resection undergoing non-operative management. Dig Liver Dis (2013) 0.79
Small intestinal bacterial overgrowth in patients with chronic pancreatitis. J Clin Gastroenterol (2014) 0.79
Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases. Neuroendocrinology (2016) 0.79
Role of BAX for outcome prediction in gastrointestinal malignancies. Med Oncol (2013) 0.78
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation? Oncology (2013) 0.78
Iron deficiency anemia caused by nonspecific (idiopathic) small bowel ulceration: an uncommon presentation of an uncommon disease. Can J Gastroenterol (2002) 0.78
Common Diagnostic Challenges in the Histopathologic Diagnosis of Neuroendocrine Lung Tumors: A Case Report. Case Rep Oncol (2010) 0.78
Pitfalls in the diagnosis of neuroendocrine tumors: atypical clinical and radiological findings as cause of medical mistakes. Tumori (2009) 0.78
Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical opportunities. Tumori (2013) 0.78
TP53 mutations in advanced colorectal cancer: the dark side of the moon. Oncology (2014) 0.77
Pleomorph poorly differentiated endocrine carcinoma of the rectum. Virchows Arch (2003) 0.77
Giant condyloma acuminatum of the anorectum: successful radical surgery with anal reconstruction. Tumori (2012) 0.77
Compassionate use of everolimus in a patient with a neuroendocrine tumor: a case report and discussion of the literature. Oncol Res (2011) 0.77
Synchronous carcinosarcoma of the intrapancreatic bile duct and carcinoma in situ of wirsung duct: a case report. Pancreas (2008) 0.77
Real-world study of everolimus in advanced progressive neuroendocrine tumors. Oncologist (2015) 0.76
Probiotics and severe acute pancreatitis. Addendum. J Clin Gastroenterol (2008) 0.76
Is entirely conservative management a correct strategy for hemodynamically stable patient with a grade IV blunt pancreatic injury? World J Surg (2011) 0.75
Of bacteria, acid, and blood. Gastroenterology (2005) 0.75
The role of SRC family kinases in neuroendocrine tumors. Gastroenterology (2012) 0.75
Re: Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst (2004) 0.75
Passive smoking and the use of noncigarette tobacco products in association with risk for pancreatic cancer: a case-control study. Cancer (2008) 0.75
Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease. JOP (2009) 0.75
Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study. Neuroendocrinology (2015) 0.75
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH. Pancreas (2016) 0.75
Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma. Anticancer Res (2012) 0.75
The Use of Complementary and Alternative Medicine is Frequent in Patients With Pancreatic Disorders. J Clin Gastroenterol (2016) 0.75
Phenotype expression in a case of adult cystic fibrosis caused by an extremely rare compound heterozygous genotype (2183AA>G/2789+5G>A). Pancreas (2009) 0.75
[Chemotherapy and NSAIDs in neoplastic disease. Role of anti-secretory preventive therapy]. Recenti Prog Med (2003) 0.75
Solitary facial metastasis of an ileal carcinoid. Acta Biomed (2003) 0.75
Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature. Am J Surg Pathol (2020) 0.75
Evaluation of the Relationships Between Computed Tomography Features, Pathological Findings, and Prognostic Risk Assessment in Gastrointestinal Stromal Tumors. J Comput Assist Tomogr (2016) 0.75
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid. Dig Liver Dis (2009) 0.75